Cited by 197Diabetes Management and ResearchHealth Systems, Economic Evaluations, Quality of LifeDiabetes Management and Education

The DOI matches its Crossref record; 49 of the 51 references it cites were found in a registry or an index.

Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method

Open access

Tao, Betty, Pietropaolo, Massimo, Atkinson, Mark, Schatz, Desmond, Taylor, David·2010·PLoS ONE

DOI 10.1371/journal.pone.0011501PMC PMC2901386

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Diabetes costs represent a large burden to both patients and the health care system. However, few studies that examine the economic consequences of diabetes have distinguished between the two major forms, type 1 and type 2 diabetes, despite differences in underlying pathologies. Combining the two diseases implies that there is no difference between the costs of type 1 and type 2 diabetes to a patient. In this study, we examine the costs of type 1 diabetes, which is often overlooked due to the larger population of type 2 patients, and compare them to the estimated costs of diabetes reported in the literature. METHODOLOGY/PRINCIPAL FINDINGS: Using a nationally representative dataset, we estimate yearly and lifetime medical and indirect costs of type 1 diabetes by implementing a matching method to compare a patient with type 1 diabetes to a similar individual without the disease. We find that each year type 1 diabetes costs this country $14.4 billion (11.5-17.3) in medical costs and lost income. In terms of lost income, type 1 patients incur a disproportionate share of type 1 and type 2 costs. Further, if the disease were eliminated by therapeutic intervention, an estimated $10.6 billion (7.2-14.0) incurred by a new cohort and $422.9 billion (327.2-519.4) incurred by the existing number of type 1 diabetic patients over their lifetime would be avoided. CONCLUSIONS/SIGNIFICANCE: We find that the costs attributed to type 1 diabetes are disproportionately higher than the number of type 1 patients compared with type 2 patients, suggesting that combining the two diseases when estimating costs is not appropriate. This study and another recent contribution provides a necessary first step in estimating the substantial costs of type 1 diabetes on the U.S.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0011501

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000
Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Strawn, L. G., Flegal, K. M., & Mei, Z. (2002) · Cited by 6,426
Matching as an econometric evaluation estimator: Evidence from evaluating a job training programme
Heckman, J. J., Ichimura, H., & Todd, P. E. (1997) · The Review of Economic Studies · doi:10.2307/2971733 · Cited by 5,486
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
2000 CDC Growth Charts for the United States: methods and development.
Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Grummer‐Strawn, L. M., Flegal, K. M., Mei, Z., Wei, R. X., Curtin, L. R., Roche, A. F., & Johnson, C. L. (2002) · PubMed · Cited by 3,716
Centers for Disease Control and Prevention 2000 Growth Charts for the United States: Improvements to the 1977 National Center for Health Statistics Version
Ogden, C. L., Kuczmarski, R. J., Flegal, K. M., Mei, Z., Guo, S. S., Wei, R. X., Grummer‐Strawn, L. M., Curtin, L. R., Roche, A. F., & Johnson, C. L. (2002) · PEDIATRICS · doi:10.1542/peds.109.1.45 · Cited by 2,017
Economic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Incidence and trends of childhood type 1 diabetes worldwide 1990–1999
The DIAMOND Project Group (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01925.x · Cited by 1,085

Flagged first, then by citations

Show all 51 references

2 of the 51 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

MI Harris, 1995, Classification, diagnostic criteria, and screening for diabetes., Diabetes in America, 2, 95

Sorted by citations

Type 1 diabetes
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Self-citation
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals
Sims, E. K., Bundy, B. N., Stier, K., Serti, E., Lim, N., Long, S. A., Geyer, S. M., Moran, A., Greenbaum, C. J., Evans-Molina, C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc8980 · Cited by 377
Self-citation
Zonulin, regulation of tight junctions, and autoimmune diseases
Fasano, A. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06538.x · Cited by 365
Experimental Diabetes Mellitus in Different Animal Models
Al-Awar, A., Kupai, K., Veszelka, M., Szűcs, G., Attieh, Z. K., Murlasits, Z., Török, S., Pósa, A., & Varga, C. (2016) · Journal of Diabetes Research · doi:10.1155/2016/9051426 · Cited by 309
ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes
de Bock, M. I., Ethel Codner, D., Craig, M. E., Huynh, T., Maahs, D. M., Mahmud, F. H., Marcovecchio, L., & DiMeglio, L. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13455 · Cited by 282
Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective
Sims, E. K., Besser, R. E. J., Dayan, C. M., Rasmussen, C. G., Greenbaum, C. J., Griffin, K., Hagopian, W., Knip, M., Long, A. E., Martin, F., et al. (2022) · Diabetes · doi:10.2337/dbi20-0054 · Cited by 274
Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: A systematic review of randomised controlled trials and meta-analysis
Teo, E., Hassan, N., Tam, W., & Koh, S. (2022) · Diabetologia · doi:10.1007/s00125-021-05648-4 · Cited by 186
Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era
Akil, A. A., Yassin, E., Al-Maraghi, A., ALIYEV, E. E., Al-Malki, K., & Fakhro, K. A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02778-6 · Cited by 217
Cost-of-illness studies of diabetes mellitus: A systematic review
Ng, C. S., Lee, J. Y. C., Toh, M. P. H., & Ko, Y. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.03.020 · Cited by 134
Engineering immunomodulatory biomaterials for type 1 diabetes
Stabler, C. L., Li, Y., Stewart, J. M., & Keselowsky, B. G. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0112-5 · Cited by 128
Design of a vascularized synthetic poly(ethylene glycol) macroencapsulation device for islet transplantation
Weaver, J. D., Headen, D., Hunckler, M. D., Coronel, M. M., Stabler, C., & García, A. J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.047 · Cited by 114
Risk of Diabetes Among Young Adults Born Preterm in Sweden
Crump, C., Winkleby, M. A., Sundquist, K., & Sundquist, J. (2011) · Diabetes Care · doi:10.2337/dc10-2108 · Cited by 114
Type 1 diabetes: role of intestinal microbiome in humans and mice
Boerner, B. P., & Sarvetnick, N. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06340.x · Cited by 109
The Epidemiology of Type 1 Diabetes in Children
Stanescu, D. E., Lord, K., & Lipman, T. H. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.08.001 · Cited by 105
Patient-Driven Diabetes Care of the Future in the Technology Era
Ashrafzadeh, S., & Hamdy, O. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.005 · Cited by 111
Impact of Patient Use of an Online Patient Portal on Diabetes Outcomes
Lau, M. C. C., Campbell, H., Tang, T. S., Thompson, D. J. S., & Elliott, T. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.10.005 · Cited by 110
Variation in Resource Use and Readmission for Diabetic Ketoacidosis in Children’s Hospitals
Tieder, J. S., McLeod, L., Keren, R., Luan, X., Localio, R., Mahant, S., Malik, F. S., Shah, S. S., Wilson, K. M., & Srivastava, R. (2013) · PEDIATRICS · doi:10.1542/peds.2013-0359 · Cited by 102
Estimated Lifetime Economic Burden of Type 1 Diabetes
Sussman, M., Benner, J., Haller, M. J., Rewers, M., & Griffiths, R. I. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0398 · Cited by 97
Hyaluronan in immune dysregulation and autoimmune diseases
Nagy, N., Kuipers, H. F., Marshall, P. L., Wang, E., Kaber, G., & Bollyky, P. L. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.022 · Cited by 94
Superior Long-term Survival for Simultaneous Pancreas-Kidney Transplantation as Renal Replacement Therapy: 30-Year Follow-up of a Nationwide Cohort
Esmeijer, K., Hoogeveen, E. K., van der Boog, P. J. M., Konijn, C., Mallat, M. J. K., Baranski, A. G., Dekkers, O. M., de Fijter, J. W., Bemelman, F. J., Nurmohamed, A. S., et al. (2019) · Diabetes Care · doi:10.2337/dc19-1580 · Cited by 89
Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model
Sturgeon, C., Lan, J., & Fasano, A. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13343 · Cited by 82
Diabetic Ketoacidosis at Diagnosis Influences Complete Remission After Treatment With Hematopoietic Stem Cell Transplantation in Adolescents With Type 1 Diabetes
Gu, W., Hu, J., Wang, W., Li, L., Tang, W. D., Sun, S., Cui, W., Ye, L., Zhang, Y., Hong, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2161 · Cited by 82
Effects of ethanol extract of propolis on histopathological changes and anti‐oxidant defense of kidney in a rat model for type 1 diabetes mellitus
Sameni, H. R., Ramhormozi, P., Bandegi, A. R., Taherian, A. A., Mirmohammadkhani, M., & Safari, M. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12459 · Cited by 77
Human Adipose-Derived Stromal/Stem Cells Protect Against STZ-Induced Hyperglycemia: Analysis of hASC-Derived Paracrine Effectors
Kono, T., Sims, E. K., Moss, D. R., Yamamoto, W. R., Ahn, G., Diamond, J. M., Tong, X., Day, K. H., Territo, P. R., Hanenberg, H., et al. (2014) · Stem Cells · doi:10.1002/stem.1676 · Cited by 76
Screening and support for emotional burdens of youth with type 1 diabetes: Strategies for diabetes care providers
Hilliard, M. E., de Wit, M., Wasserman, R. M., Butler, A. M., Evans, M. A., Weissberg-Benchell, J. A., & Anderson, B. J. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12575 · Cited by 72
A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes.
Ataie-Jafari, A., Loke, S., Rahmat, A., Larijani, B., Abbasi, F., Leow, M., & Yassin, Z. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.01.012 · Cited by 60
Synthetic poly(ethylene glycol)-based microfluidic islet encapsulation reduces graft volume for delivery to highly vascularized and retrievable transplant site
Weaver, J. D., Headen, D., Coronel, M. M., Hunckler, M. D., Shirwan, H., & García, A. J. (2018) · American Journal of Transplantation · doi:10.1111/ajt.15168 · Cited by 62
Direct Medical Cost of Type 2 Diabetes in Singapore
Ng, C. S., Toh, M. P. H. S., Ko, Y., & Lee, J. Y.-C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122795 · Cited by 63
New Approaches to Providing Individualized Diabetes Care in the 21st Century
Powell, P. W., Corathers, S. D., Raymond, J. K., & Streisand, R. M. (2015) · Current Diabetes Reviews · doi:10.2174/1573399811666150421110316 · Cited by 60
Deep Multi-Output Forecasting
Fox, I., Ang, L. P., Jaiswal, M., Pop‐Busui, R., & Wiens, J. (2018) · ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD) · doi:10.1145/3219819.3220102 · Cited by 79
Local Immunomodulatory Strategies to Prevent Allo‐Rejection in Transplantation of Insulin‐Producing Cells
Wang, X., Brown, N. K., Wang, B., Shariati, K., Wang, K., Fuchs, S., Melero‐Martin, J. M., & Ma, M. (2021) · Advanced Science · doi:10.1002/advs.202003708 · Cited by 57
Exposure to the Viral By-Product dsRNA or Coxsackievirus B5 Triggers Pancreatic Beta Cell Apoptosis via a Bim / Mcl-1 Imbalance
Colli, M. L., Nogueira, T. C., Allagnat, F., Cunha, D. A., Gurzov, E. N., Cardozo, A. K., Roivainen, M., Beeck, A. O. D., & Eizirik, D. L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002267 · Cited by 57
Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort
Burisch, J. M., Vardi, H., Pedersen, N. K., Brinar, M., Cukovic-Cavka, S., Kaimakliotis, I. P., Ďuricová, D., Bortlík, M., Shonová, O., Vind, I., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000250 · Cited by 54
A health economic analysis of clinical islet transplantation
Beckwith, J., Nyman, J. A., Flanagan, B., Schrover, R., & Schuurman, H. (2011) · Clinical Transplantation · doi:10.1111/j.1399-0012.2011.01411.x · Cited by 51
Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis
REDONDO, M. J., Oram, R. A., & Steck, A. K. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0961-5 · Cited by 53
Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow-up in a Danish Population-based Inception Cohort
Lo, B. Z. S., Vind, I., Vester-Andersen, M. K., Bendtsen, F., & Burisch, J. M. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz096 · Cited by 50
Costs of Public Health Screening of Children for Presymptomatic Type 1 Diabetes in Bavaria, Germany
Karl, F. M., Winkler, C., Ziegler, A., Laxy, M., & Achenbach, P. (2022) · Diabetes Care · doi:10.2337/dc21-1648 · Cited by 53
A critical review and analysis of ethical issues associated with the artificial pancreas
Quintal, A., Messier, V., RABASA-LHORET, R. P. R., & Racine, É. (2018) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.04.003 · Cited by 48
Towards antigen-specific Tregs for type 1 diabetes: Construction and functional assessment of pancreatic endocrine marker, HPi2-based chimeric antigen receptor
Radichev, I., Yoon, J., Scott, D. W., Griffin, K., & Savinov, A. Y. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104224 · Cited by 42
Healthcare resource utilization and cost among patients with type 1 diabetes in the United States
Simeone, J. C., Shah, S., Ganz, M. L., Sullivan, S., Koralova, A., LeGrand, J., & Bushman, J. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.11.1399 · Cited by 41
Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet’s Pathway to Prevention
Sims, E., Geyer, S., Johnson, S. B., Libman, I., Jacobsen, L. M., Boulware, D., Rafkin, L., Matheson, D., Atkinson, M., Rodriguez, H., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0593 · Cited by 34
Self-citation
Diabetes MILES – The Netherlands: rationale, design and sample characteristics of a national survey examining the psychosocial aspects of living with diabetes in Dutch adults
Nefs, G., Bot, M., Browne, J. L., Speight, J., & Pouwer, F. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-925 · Cited by 38
Patient and Healthcare Professionals Perspectives on the Delivery of Exercise Education for Patients With Type 1 Diabetes
Litchfield, I. J., Andrews, R. C., Narendran, P., & Greenfield, S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00076 · Cited by 40
A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus
Henriksson, M., Jindal, R., Sternhufvud, C., Bergenheim, K., Sörstadius, E., & Willis, M. S. (2016) · PharmacoEconomics · doi:10.1007/s40273-015-0374-8 · Cited by 36
Bio-synthetic materials for immunomodulation of islet transplants
Foster, G. A., & Garcı́a, A. J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.012 · Cited by 35
Changing costs of type 1 diabetes care among US children and adolescents
Crossen, S. S., Xing, G., & Hoch, J. S. (2020) · Pediatric Diabetes · doi:10.1111/pedi.12996 · Cited by 36
Comparison of osteoporosis in US adults with type 1 and type 2 diabetes mellitus
DeShields, S. C., & Cunningham, T. D. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0828-x · Cited by 36
Recent Advances in Smart Biomaterials for the Detection and Treatment of Autoimmune Diseases
Shodeinde, A. B., Murphy, A. C., Oldenkamp, H. F., Potdar, A. S., Ludolph, C. M., & Peppas, N. A. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909556 · Cited by 36
Direct Diabetes-Related Costs in Young Patients with Early-Onset, Long-Lasting Type 1 Diabetes
Bächle, C., Icks, A., Strassburger, K., Flechtner-Mors, M., Hungele, A., Beyer, P., Placzek, K., Hermann, U., Schumacher, A., Freff, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070567 · Cited by 34
A Key to T1D Prevention: Screening and Monitoring Relatives as Part of Clinical Care
Greenbaum, C. J. (2021) · Diabetes · doi:10.2337/db20-1112 · Cited by 34
Cost analysis of type 2 diabetes mellitus treatment in economically developed countries
Ramzan, S., Timmins, P., Hasan, S. S., & Babar, Z. (2018) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2018.1513790 · Cited by 31
Cost-Effectiveness Analysis of a Hybrid Closed-Loop System Versus Multiple Daily Injections and Capillary Glucose Testing for Adults with Type 1 Diabetes
Pease, A., Zomer, E., Liew, D., Earnest, A., Soldatos, G., Ademi, Z., & Zoungas, S. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0064 · Cited by 39
Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol
McAuley, S. A., de Bock, M. I., Sundararajan, V., Lee, M. H., Paldus, B., Ambler, G. R., Bach, L. A., Burt, M. G., Cameron, F. J., Clarke, P., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020274 · Cited by 29
A cross-sectional study of self-reported general health, lifestyle factors, and disease: the Hordaland Health Study
Jepsen, R., Dogisso, T. W., Dysvik, E., Andersen, J. R., & Natvig, G. K. (2014) · PeerJ · doi:10.7717/peerj.609 · Cited by 32
Inhibition of polyamine biosynthesis preserves β cell function in type 1 diabetes
Sims, E. K., Kulkarni, A., Hull, A., Woerner, S. E., Cabrera, S. M., Mastrandrea, L. D., Hammoud, B., Sarkar, S., Nakayasu, E. S., Mastracci, T. L., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101261 · Cited by 31
Impact of type 2 diabetes on health expenditure: estimation based on individual administrative data
Baudot, F.-O., Aguadé, A.-S., Barnay, T., Gastaldi‐Ménager, C., & Fagot‐Campagna, A. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-018-1024-9 · Cited by 27
Estimation of Annual Health Care Costs for Adults with Type 1 Diabetes in the United States
Joish, V. N., Zhou, F. L., Preblick, R., Lin, D., Deshpande, M., Verma, S., Davies, M. J., Paranjape, S., & Pettus, J. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.3.311 · Cited by 27
Differential Profile of Plasma Circular RNAs in Type 1 Diabetes Mellitus
Li, Y., Zhou, Y., Zhao, M., Zou, J., Zhu, Y., Yuan, X., Liu, Q., Cai, H., Chu, C., & Liu, Y. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0151 · Cited by 28
Trajectory of Excess Medical Expenditures 10 Years Before and After Diabetes Diagnosis Among U.S. Adults Aged 25–64 Years, 2001–2013
Shrestha, S. S., Zhang, P., HORA, I. A., & Gregg, E. W. (2018) · Diabetes Care · doi:10.2337/dc17-2683 · Cited by 27
Glycated Hemoglobin Differences Among Blog-Reading Adults With Type 1 Diabetes Compared With Those Who Do Not Read Blogs: Cross-Sectional Study
Oser, S. M., Stuckey, H. L., Parascando, J. A., McGinley, E. L., Berg, A. S., & Oser, T. K. (2019) · JMIR Diabetes · doi:10.2196/13634 · Cited by 27
Clinical implementation of islet transplantation: A current assessment
Bottino, R., & Trucco, M. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12287 · Cited by 25
Adjuvant immunotherapy: the sting in the tail
Higham, C., Chatzimavridou-Grigoriadou, V., Fitzgerald, C. T., Trainer, P. J., Eggermont, A. M. M., & Lorigan, P. C. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.03.016 · Cited by 25
Deep Multi-Output Forecasting: Learning to Accurately Predict Blood Glucose Trajectories
Fox, I., Ang, L. P., Jaiswal, M., Pop‐Busui, R., & Wiens, J. (2018) · PubMed · doi:10.48550/arxiv.1806.05357 · Cited by 24
Periodontal disease, smoking, cardiovascular complications and mortality in type 1 diabetes
Khouja, T., Miller, R. G., Moore, P. A., Orchard, T. J., & Costacou, T. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.05.025 · Cited by 25
A Digital Health Intervention (SweetGoals) for Young Adults With Type 1 Diabetes: Protocol for a Factorial Randomized Trial
Stanger, C., Kowatsch, T., Xie, H., Nahum-Shani, I. B., Lim-Liberty, F., Anderson, M. A. B., Santhanam, P., Kaden, S. J., & Rosenberg, B. (2021) · JMIR Research Protocols · doi:10.2196/27109 · Cited by 22
Cause or effect? A review of clinical data demonstrating beta cell dysfunction prior to the clinical onset of type 1 diabetes
Sims, E. K., & DiMeglio, L. A. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.010 · Cited by 22
Therapeutic Effects of BCG Vaccination on Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Chang, Y., Lin, C., Hsiao, Y.-H., Chang, Y.-H., Liu, S., & Hsu, H. (2020) · Journal of Diabetes Research · doi:10.1155/2020/8954125 · Cited by 23
Cost of illness studies on reproductive, maternal, newborn, and child health: a systematic literature review
Saha, S., & Gerdtham, U. (2013) · Health Economics Review · doi:10.1186/2191-1991-3-24 · Cited by 23
Systematic Review
Pieścik‐Lech, M., Chmielewska, A., Shamir, R., & Szajewska, H. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001293 · Cited by 27
Emerging Concepts on Disease-Modifying Therapies in Type 1 Diabetes
Greenbaum, C. J., Lord, S. M., & VanBuecken, D. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0932-x · Cited by 24
Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells
Leung, S. S., Borg, D. J., McCarthy, D. A., Boursalian, T. E., Cracraft, J., Zhuang, A., Fotheringham, A. K., Flemming, N., Watkins, T. S., Miles, J. J., et al. (2022) · Diabetes · doi:10.2337/db22-0177 · Cited by 23
Hospital and ED charges for spina bifida care in the United States between 2006 and 2014: Over $2 billion annually.
Inouye, B. M., Jiang, R., Alkazemi, M. H., Wang, H. S., Wolf, S. P., Pomann, G., Tejwani, R., Wiener, J. S., Purves, J. T., & Routh, J. C. (2019) · Disability and health journal · doi:10.1016/j.dhjo.2019.01.007 · Cited by 22
A randomized clinical trial aimed at preventing poor psychosocial and glycemic outcomes in teens with type 1 diabetes (T1D)
Weissberg-Benchell, J. A., Rausch, J. R., Iturralde, E., Jedraszko, A. M., & Hood, K. K. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.05.006 · Cited by 22
Targeting Type 1 Diabetes: Selective Approaches for New Therapies
Sheehy, D. F., Quinnell, S. P., & Vegas, A. J. (2019) · Biochemistry · doi:10.1021/acs.biochem.8b01118 · Cited by 23
Systematic review of sociodemographic representation and cultural responsiveness in psychosocial and behavioral interventions with adolescents with type 1 diabetes
Morone, J. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12889 · Cited by 20
Long-term follow-up of patients with atherosclerotic renal artery disease
Şafak, E., Wilke, C., Derer, W., Busjahn, A., Gross, M. C., Möckel, M. M., Mueller, D. N., Luft, F. C., & Dechend, R. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2012.12.001 · Cited by 20
Economics of Type 1 Diabetes
Tao, B. T., & Taylor, D. G. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.004 · Cited by 20
Self-citation
Economics of Beta-Cell Replacement Therapy
Bandeiras, C., Hwa, A. J., Cabral, J. M. S., Ferreira, F. C., Finkelstein, S. N., & Gabbay, R. A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1203-9 · Cited by 19
Measuring psychological flexibility in youth with type 1 diabetes
Berlin, K. S., Keenan, M., Cook, J. L., Ankney, R. L., Klages, K. L., Semenkovich, K. A., Rybak, T., Banks, G. G., Alemzadeh, R., & Eddington, A. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13110 · Cited by 13
Cost Effectiveness of Teplizumab for Prevention of Type 1 Diabetes Among Different Target Patient Groups
Mital, S., & Nguyen, H. V. (2020) · PharmacoEconomics · doi:10.1007/s40273-020-00962-y · Cited by 19
Prevalence of chronic kidney disease in an admixed population of patients with type 1 diabetes. A multicenter study in Brazil
Gomes, M. B., Pizarro, M., Muniz, L. H., Barros, B. S. V., Melo, L. G. N., Santos, D. C., & Negrato, C. A. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108490 · Cited by 19
Diabetes mellitus tipo1: factores psicosociales y adaptación del paciente pediátrico y su familia. Revisión
Pérez‐Marín, M., Gómez-Rico, I., & Montoya‐Castilla, I. (2015) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2015.158 · Cited by 19
Bringing Stem Cell‐Based Therapies for Type 1 Diabetes to the Clinic: Early Insights from Bioprocess Economics and Cost‐Effectiveness Analysis
Bandeiras, C., Cabral, J. M. S., Gabbay, R. A., Finkelstein, S. N., & Ferreira, F. C. (2019) · Biotechnology Journal · doi:10.1002/biot.201800563 · Cited by 19
The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth
Pease, A., Callander, E. J., Zomer, E., Abraham, M. B., Davis, E. A., Jones, T. W., Liew, D., & Zoungas, S. (2022) · Diabetes Care · doi:10.2337/dc21-2019 · Cited by 19
Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States
BISKUPIAK, J. E., Ramos, M., Levy, C. J., Forlenza, G. P., Hopley, C. D. J., Boyd, J., Swift, D., Lamotte, M., & Brixner, D. I. (2023) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2023.22331 · Cited by 18
Health Care Provider Knowledge and Perceptions of FDA-Approved and Do-It-Yourself Automated Insulin Delivery
Murray, J. A., Clayton, M. F., & Litchman, M. L. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819895567 · Cited by 17
The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes
Inoue, R., Nishiyama, K., Li, J., Miyashita, D., Ono, M., Terauchi, Y., & Shirakawa, J. (2021) · Cells · doi:10.3390/cells10071589 · Cited by 20
Cost Analysis of Type 1 Diabetes Illness in Terms of Patient Perspectives
Meltem, S. A. R. I., & Bozdemir, E. (2022) · Sağlık ve Hemşirelik Yönetimi Dergisi · doi:10.54304/shyd.2022.47550 · Cited by 16
A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus
Henriksson, M., Jindal, R., Sternhufvud, C., Sörstadius, E., Bergenheim, K., & Willis, M. S. (2015) · Value in Health · doi:10.1016/j.jval.2015.09.2097 · Cited by 15
Medical Costs Associated With Diabetes Complications in Medicare Beneficiaries Aged 65 Years or Older With Type 1 Diabetes
Wang, Y., Zhang, P., Shao, H., Andes, L. J., & Imperatore, G. (2022) · Diabetes Care · doi:10.2337/dc21-2538 · Cited by 14
Recent Rates of Substance Use Among Adolescents and Young Adults with Type 1 Diabetes in the USA
Sannegowda, R., Villalba, K., Suk, R., Gurnurkar, S., & Wasserman, R. M. (2023) · Current Diabetes Reports · doi:10.1007/s11892-022-01496-7 · Cited by 14
Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes
Haller, M. J., Atkinson, M. A., Wasserfall, C. H., Brusko, T. M., Mathews, C. E., Hulme, M. A., Cintrón, M., Shuster, J. J., McGrail, K., Posgai, A. L., et al. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12731 · Cited by 14
Self-citation
Generating β-cells in vitro
Fryer, B. H., Rezania, A., & Zimmerman, M. C. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835edb4c · Cited by 14
Financial Advice Use and Saving for Children’s College Education: A Propensity Score Matching Approach
Korankye, T., Pearson, B. M., & Salehi, H. (2023) · Journal of Financial Counseling and Planning · doi:10.1891/jfcp-2021-0069 · Cited by 18
The Long-Run Effects of Cesarean Sections
Costa-Ramón, A., Kortelainen, M., Rodríguez‐González, A., & Sääksvuori, L. (2020) · The Journal of Human Resources · doi:10.3368/jhr.58.2.0719-10334r1 · Cited by 15
Preterm birth and economic benefits of reduced maternal exposure to fine particulate matter
Kim, J. J., Axelrad, D. A., & Dockins, C. (2018) · Environmental Research · doi:10.1016/j.envres.2018.12.013 · Cited by 13
Understanding Competitive Endogenous RNA Network Mechanism in Type 1 Diabetes Mellitus Using Computational and Bioinformatics Approaches
Yi, X., & Xu, C. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s315488 · Cited by 15
Impact and Cost-Effectiveness of Integrated Psychology Services in a Pediatric Endocrinology Clinic
Caccavale, L. J., Bernstein, R. M., Yarbro, J., Rushton, H., Gelfand, K. M., & Schwimmer, B. A. (2019) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-019-09645-z · Cited by 12
Effect of Different Glucose Monitoring Methods on Bold Glucose Control: A Systematic Review and Meta-Analysis
Wang, Y., Zou, C., Na, H., Zeng, W., & Li, X. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/2851572 · Cited by 12
Micro/nanobubbles
Sayadi, L. R., Alexander, M., Sorensen, A. M., Sarantopoulos, N., Lau, H., Klopfer, M. J., Ziegler, M. E., Banyard, D. A., Evans, G. R. D., Lakey, J. R. T., et al. (2019) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000001954 · Cited by 12

Authors: Tao, B., Pietropaolo, M., Atkinson, M., Schatz, D., & Taylor, D.
Affiliations: University of Michigan (US)
University of Florida (US)
Center for Naval Analyses (US)
Corresponding author: Tao, Betty
ORCID: Pietropaolo, Massimo
Atkinson, Mark
Schatz, Desmond
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2010-07-09
Volume: 5
Issue: 7
Pages: e11501
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0011501
PMC: PMC2901386
OpenAlex: W2093172018
Cited by: 197
References: 51
Citations by year: 2026: 7 · 2025: 8 · 2024: 8 · 2023: 13 · 2022: 18 · 2021: 15 · 2020: 21 · 2019: 20 · 2018: 17 · 2017: 8 · 2016: 12 · 2015: 11 · 2014: 11 · 2013: 12 · 2012: 8
FWCI: 6.78
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: University of Michigan
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK053456)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords: type 1 diabetes, health care costs, indirect costs, income loss, lifetime costs, economic burden, type 2 diabetes, cost comparison, economic burden of disease, cost avoidance
MeSH terms: Diabetes Mellitus, Type 1, Female, Humans, Male, Models, Theoretical, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks